 Studies show that some medicines that lower cholesterol may reduce the risk of developing Alzheimers disease, but this has not yet been proven in humans. We are looking for individuals to participate in this study to see if a cholesterol-lowering medication, called simvastatin affects blood flow to the brain, blood vessel function and a substance in the spinal fluid related to the changes in Alzheimers disease. 